Treace Medical Concepts Q4 Earnings Summary & Key Takeaways
Treace Medical Concepts, Inc. TMCI | 1.34 1.34 | -6.94% 0.00% Post |
Treace Medical Concepts (NASDAQ:TMCI) released its Q4 earnings on Friday, February 27, 2026 at 07:05 AM.
Here's what's important from the earnings announcement.
Earnings
Treace Medical Concepts missed estimated earnings by -7.14%, reporting an EPS of $-0.15 versus an estimate of $-0.14.
Revenue was down $6.19 million from the same period last year.
Past Earnings Performance
In the previous quarter, the company beat on EPS by $0.01, resulting in a 28.33% drop change in the share price the following day.
Here's a look at Treace Medical Concepts's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.27 | -0.29 | -0.30 | -0.04 |
| EPS Actual | -0.26 | -0.28 | -0.25 | -0.01 |
| Revenue Estimate | 49.59M | 47.05M | 52.70M | 67.19M |
| Revenue Actual | 50.21M | 47.39M | 52.57M | 68.71M |
To track all earnings releases for Treace Medical Concepts visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.